Abstract
The present contribution summarizes the results of treating acute myeloid leukemia (AML) with aclarubicin (ACM) in three consecutive studies. Some of the results have recently been published elsewhere [1–3].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Mitrou PS, Kuse R, Anger H et al. (1985) Aclarubicin ( Aclacinomycin A) in the treatment of relapsing acute leukaemias. Eur J Cancer Clin Oncol 21: 919–923
Mitrou PS (1985) Aclarubicin in single agent and combined chemotherapy of acute myeloid leukaemias. Eur J Haematol 38 (Suppl 47): 59–65
Oka S, Mathe G, Mitrou PS (1984) Cancer Treat Rev 11: 299–302
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Mitrou, P.S. (1990). Aclarubicin in Single Agent and Combined Chemotherapy of Adult Acute Myeloid Leukemia. In: Hiddemann, W., Mertelsmann, R. (eds) New Findings on Aclarubicin in the Treatment of Acute Myeloid Leukemia. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75720-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-75720-4_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-52613-1
Online ISBN: 978-3-642-75720-4
eBook Packages: Springer Book Archive